Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05028153 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05028153 · ClinicalTrials.gov record · last posted 2025-04-13

Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms

Study acronym: COPSACazt
StatusRecruiting
PhasePhase 2
Started2022-11-14
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The purpose of this double-blind, randomized, controlled clinical trial is to investigate the effect of a three-day azithromycin treatment versus placebo treatment in children aged 1-5 years who are hospitalized due to asthma-like symptoms.

Amendment record 5 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 5 times since 2021-08-24; most recent amendment 2025-04-09. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2023-02-07
Status change Not Yet Recruiting→Recruitingv3
Trial Details
NCT Number NCT05028153
Lead Sponsor Copenhagen Studies on Asthma in Childhood
Conditions Childhood Asthma With Acute Exacerbation
Enrollment 320 participants
Start Date 2022-11-14
Primary Completion 2026-11-13 (estimated)
Study Completion 2032-11-13 (estimated)
Updated on ClinicalTrials.gov 2025-04-13